Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma.

[1]  N. Langkilde,et al.  Frequency and mechanism of Lewis antigen expression in human urinary bladder and colon carcinoma patients. , 1991, British Journal of Cancer.

[2]  S. Kawa,et al.  Loss of Lewis antigen expression on erythrocytes in some cancer patients with high serum CA19-9 levels. , 1987, Journal of the National Cancer Institute.

[3]  D. Longo,et al.  Use of serum tumor markers in cancer diagnosis and management. , 1987, Seminars in oncology.

[4]  A. Fasoli.  [Clinical decision analysis]. , 1986, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna.

[5]  O. Nilsson,et al.  Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody , 1985, FEBS letters.

[6]  O. Nilsson,et al.  Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. , 1984, British medical journal.

[7]  O. Mäkelä,et al.  Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. , 1984, British Journal of Cancer.

[8]  H. Koprowski,et al.  Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. , 1983, Cancer research.

[9]  O. Nilsson,et al.  Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. , 1983, International archives of allergy and applied immunology.

[10]  M. Brockhaus,et al.  A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. , 1982, The Journal of biological chemistry.

[11]  M. Brockhaus,et al.  LEWIS BLOOD-TYPE MAY AFFECT THE INCIDENCE OF GASTROINTESTINAL CANCER , 1982, The Lancet.

[12]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[13]  M. Herlyn,et al.  Colorectal carcinoma antigens detected by hybridoma antibodies , 1979, Somatic cell genetics.

[14]  C. Metz.  Basic principles of ROC analysis. , 1978, Seminars in nuclear medicine.

[15]  Z. Bentwich,et al.  Carcinoembryonic Antigen , 1978 .

[16]  D Rodbard,et al.  Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. , 1974, Clinical chemistry.

[17]  J. Swets.  The Relative Operating Characteristic in Psychology , 1973, Science.

[18]  Phil Gold,et al.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES , 1965, The Journal of experimental medicine.

[19]  F. A. Coller,et al.  THE PROGNOSTIC SIGNIFICANCE OF DIRECT EXTENSION OF CARCINOMA OF THE COLON AND RECTUM , 1954, Annals of surgery.

[20]  M. Schwartz.  Advances in the use of tumor markers. , 1990, Comprehensive therapy.

[21]  N. Petrelli,et al.  Serum levels of cancer‐associated antigen ca‐195 in gastrointestinal cancers and its comparison with ca19‐9 , 1989, Journal of clinical laboratory analysis.

[22]  K. Bray,et al.  Serum levels of cancer‐associated antigen 195, a circulating marker for colon cancer, and its relationship to carcinoembryonic antigen , 1988 .

[23]  U. Sundaram,et al.  Evaluation of antigen CA-195 for the detection of colon cancer , 1987 .

[24]  N. Petrelli,et al.  Circulating CA-195 in colorectal cancer , 1987 .

[25]  W. Watkins.  Biochemistry and Genetics of the ABO, Lewis, and P blood group systems. , 1980, Advances in human genetics.

[26]  D.,et al.  Regression Models and Life-Tables , 2022 .